Health TrialsbyHealthPanel

Anterior vs Posterior vs Combined Intra-Articular Injections for Adhesive Capsulitis

ConditionsAdhesive Capsulitis of the ShoulderIntra Articular Injection
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorAslinur Keles Ercisli, MD, PhD

About this trial

This randomized controlled clinical trial aims to compare the efficacy of three different intra-articular injection approaches (anterior, posterior, and combined anterior-posterior) in patients with adhesive capsulitis of the shoulder. Thirty participants will be randomly assigned to one of three groups and treated with a standardized injection solution consisting of corticosteroid, lidocaine, and saline. Clinical outcomes will be evaluated using pain scores, functional scales, and imaging parameters.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Intervention Name: Posterior Intra-articular Injection

    Drug

    A single intra-articular injection consisting of 1 cc corticosteroid, 4 cc 2% lidocaine, and 5 cc saline (total 10 cc) administered via the posterior glenohumeral approach.

  • Anterior Intra-articular Injection

    Drug

    A single intra-articular injection consisting of 1 cc corticosteroid, 4 cc 2% lidocaine, and 5 cc saline (total 10 cc) administered via the anterior (rotator interval) approach.

  • Combined Anterior + Posterior Intra-articular Injection

    Drug

    A single intra-articular injection consisting of 1 cc corticosteroid, 4 cc 2% lidocaine, and 5 cc saline (total 10 cc) administered using both anterior and posterior approaches during the same procedure.

Treatment groups

30 Participants
are divided into 3 treatment groups
Group A: Arm A: Posterior InjectionExperimental treatment 1 intervention
Group B: Arm B - Anterior InjectionExperimental treatment 1 intervention
Group C: Arm C - Combined Anterior + Posterior InjectionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in Shoulder Range of Motion (ROM)

Change in active and passive shoulder joint range of motion (flexion, extension, abduction, external rotation, internal rotation) measured with a goniometer.

Time frame
Baseline, immediately post-injection, week 3, week 6, week 12

Secondary outcomes

1

Change in Pain Intensity (NRS)

Number Rating Scale (0-10) for pain at rest, during activity, and at night.

Time frame
Baseline, immediately post-injection, week 3, week 6, week 12
2

Subjective Shoulder Value (SSV)

Patient's self-reported percentage of normal shoulder function (0-100%).

Time frame
Baseline, immediately post-injection, week 3, week 6, week 12
3

Shoulder Pain and Disability Index (SPADI)

Questionnaire assessing pain and disability (0-100 score, higher scores = worse function).

Time frame
Baseline, week 3, week 6, week 12
4

Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH)

Questionnaire measuring upper limb disability and symptoms (0-100 score, higher = worse).

Time frame
Baseline, week 3, week 6, week 12

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Aslinur Keles Ercisli, MD, PhD

Lead sponsor

Fatih Sultan Mehmet Training and Research Hospital

Sponsor institution

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: